SCHEMBL5059356

SCHEMBL5059356

CC(=O)OOC(=O)c1cccc2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.53
NR4A2 P43354 1/20 0.53
NR4A3 Q92570 1/20 0.53
KMT2A Q03164 3/20 0.53
POLB P06746 2/20 0.53
GAA P10253 1/20 0.53
PLK1 P53350 1/20 0.51
CDC25B P30305 2/20 0.50
MMP3 P08254 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
PTPN1 P18031 1/20 0.47
ALDH1A1 P00352 4/20 0.47
HPGD P15428 4/20 0.47
MAPT P10636 3/20 0.47
KDM4E B2RXH2 4/20 0.47
ADRB2 P07550 2/20 0.46
ADRB1 P08588 2/20 0.46
ADRB3 P13945 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29990575 0.91 NR4A1 (0.63) NR4A1NR4A2NR4A3KMT2APOLB
SCHEMBL5987790 0.91 NR4A1 (0.63) NR4A1NR4A2NR4A3KMT2APOLB
SCHEMBL28483908 0.89 NR4A1 (0.61) NR4A1NR4A2NR4A3KMT2APOLB
SCHEMBL775617 0.84 NR4A1 (0.55) NR4A1NR4A2NR4A3KMT2APOLB
SCHEMBL9165434 0.82 NR4A1 (0.53) NR4A1NR4A2NR4A3KMT2APOLB
SCHEMBL27450916 0.82 NR4A1 (0.53) NR4A1NR4A2NR4A3KMT2APOLB
SCHEMBL29580762 0.79 MAPT (0.63) NR4A1NR4A2NR4A3KMT2APOLB
SCHEMBL522791 0.79 MAPT (0.63) NR4A1NR4A2NR4A3KMT2APOLB
SCHEMBL10414429 0.79 ALDH1A1 (0.54) NR4A1NR4A2NR4A3KMT2APOLB
SCHEMBL137605 0.79 NR4A1 (0.63) NR4A1NR4A2NR4A3KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420396-B2 For delivering DNA/RNA into cells SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2013-04-16 US disclosed
US-20080071069-A1 CONJUGATES AND PROCESSES FOR THEIR PREPARATION AND THEIR USE FOR TRANSPORTING MOLECULES ACROSS BIOLOGICAL MEMBRANES SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080071069-A1 CONJUGATES AND PROCESSES FOR THEIR PREPARATION AND THEIR USE FOR TRANSPORTING MOLECULES ACROSS BIOLOGICAL MEMBRANES EPCAM, ABCB1, ABCB11 NR4A1 4531/4885NR4A2 4687/4885NR4A3 4632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.